HJC0152, a novel STAT3 inhibitor with promising anti-tumor effect in gastric cancer

BACKGROUND: Aberrant activation of the signal transducer and activator of transcription 3 (STAT3) is frequently seen in patients with gastric cancer (GC), and is generally associated with worse prognosis. HJC0152, a novel STAT3 inhibitor, has shown significant anti-tumor effects in several cancers,...

Full description

Saved in:
Bibliographic Details
Published in:Cancer Manag Res
Main Authors: Jiang, Xiaoxia, Wu, Mengjie, Xu, Zhenzhen, Wang, Haohao, Wang, Haiyong, Yu, Xiongfei, Li, Zhongqi, Teng, Lisong
Format: Artigo
Language:Inglês
Published: Dove Medical Press 2018
Subjects:
Original Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6296682/
https://ncbi.nlm.nih.gov/pubmed/30588091
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S188364
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items